InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,965.20
(
0.36%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.13
(
-0.34%
)
Bitcoin
57,453.15
(
1.32%
)
Post# of 252526
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 44
Posts 4597
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: RockRat post# 104154

Tuesday, 09/14/2010 9:08:45 AM

Tuesday, September 14, 2010 9:08:45 AM

Post# of 252526

looking at this, I see it's all in vitro, and I don't see the embodiments relating to PK and PD, that is, if they are there, I am not recognizing them as such



it's an invention relating to an in vitro bioassay for copaxone. so it covers PD. One argument TEVA makes for the need for trials is that there is no in vitro bioassay for copaxone like there is for lovenox (factor Xa and IIa activity)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up